Experience

Fate Therapeutics Inc

• United States
• Biotechnology Research
• 200 - 300 Employee

• Principal Scientist

  • Mar 2022 - Present



The Duke Human Vaccine Institute

• United States
• Research
• 100 - 200 Employee

• Senior Research Scientist

  • Sep 2021 - Mar 2022

• Research Scientist

  • Mar 2020 - Sep 2021

  Analysis of the immune response to SARS-CoV-2 infection and vaccination, with focus on pediatric population. Study of virus specific immune responses in infants infected with HIV or receiving a protective and/or therapeutic vaccine, including non-human primate model. Analysis of correlates of protection compared to adults. Strategies to prevent mother-to-child transmission.



University of North Carolina at Chapel Hill School of Medicine

• United States
• Higher Education
• 700 & Above Employee

• Research Instructor

  • Aug 2017 - Feb 2020

  Expansion and Genetic modification of Natural Killer cells as immunotherapy against persistent HIV infection Evaluation of bispecific molecules to clear the latent reservoir Study of mAb combinations to promote ADCC Development of a humanized mouse model to evaluate immunotherapies against latent HIV Expansion and Genetic modification of Natural Killer cells as immunotherapy against persistent HIV infection Evaluation of bispecific molecules to clear the latent reservoir Study of mAb combinations to promote ADCC Development of a humanized mouse model to evaluate immunotherapies against latent HIV



University of North Carolina at Chapel Hill

• United States
• Higher Education
• 700 & Above Employee

• Research Associate

  • Jun 2016 - Jul 2017

• Postdoctoral Scholar

  • Jun 2011 - May 2016

  Research focused in HIV eradication. Main project about enhancing the immune response to improve clearance of HIV infected cells after latency disruption. Specific focus in natural killer cells, working in patients primary cells. Completed project about the use of gold nanoparticles to improve drug delivery to the Central Nervous System (CNS). Cell and Molecular Biology techniques: Cell Isolation, Cell culture (primary and cell line), Viral Outgrowth Assays from Resting CD4+T-cells, in… Show more Research focused in HIV eradication. Main project about enhancing the immune response to improve clearance of HIV infected cells after latency disruption. Specific focus in natural killer cells, working in patients primary cells. Completed project about the use of gold nanoparticles to improve drug delivery to the Central Nervous System (CNS). Cell and Molecular Biology techniques: Cell Isolation, Cell culture (primary and cell line), Viral Outgrowth Assays from Resting CD4+T-cells, in vitro and ex vivo Immune Function Assays, Flow Cytometry (including analysis using FlowJo), Virus Infection and Inhibition Assays, Confocal Microscopy, ELISA, Transfection, PCR Optimization, Tissue Processing, Immunohistochemistry.



Hospital Carlos III

• Madrid Area, Spain

• PHD student

  • Mar 2006 - May 2011

  Worked in the Molecular Biology Lab, researching about HIV drug resistance, HIV tropism and the use of dried blood spots (DBS) for infection follow-up in resource limited settings. PhD dissertation focused in integrase inhibitors. Active participation in WHO program ResNet evaluating methods to monitor drug resistance in developing countries. Participant in an International Cooperation Project based on HIV and HBV diagnosis implementation in a rural clinic in the northern region of Ghana. Stage… Show more Worked in the Molecular Biology Lab, researching about HIV drug resistance, HIV tropism and the use of dried blood spots (DBS) for infection follow-up in resource limited settings. PhD dissertation focused in integrase inhibitors. Active participation in WHO program ResNet evaluating methods to monitor drug resistance in developing countries. Participant in an International Cooperation Project based on HIV and HBV diagnosis implementation in a rural clinic in the northern region of Ghana. Stage in Diagnostic Hybrids, Cleveland, OH, to perform phenotypic assays to determine drug resistance in clinical samples. Molecular and Cell Biology techniques: Nucleic Acid isolation and Purification, Primer Design and Reaction Optimization, Gel Electrophoresis, Sequencing, Sequence Analysis, RT-PCR, Phylogeny, Drug Resistance Phenotypic Assays. Show less Worked in the Molecular Biology Lab, researching about HIV drug resistance, HIV tropism and the use of dried blood spots (DBS) for infection follow-up in resource limited settings. PhD dissertation focused in integrase inhibitors. Active participation in WHO program ResNet evaluating methods to monitor drug resistance in developing countries. Participant in an International Cooperation Project based on HIV and HBV diagnosis implementation in a rural clinic in the northern region of Ghana. Stage… Show more Worked in the Molecular Biology Lab, researching about HIV drug resistance, HIV tropism and the use of dried blood spots (DBS) for infection follow-up in resource limited settings. PhD dissertation focused in integrase inhibitors. Active participation in WHO program ResNet evaluating methods to monitor drug resistance in developing countries. Participant in an International Cooperation Project based on HIV and HBV diagnosis implementation in a rural clinic in the northern region of Ghana. Stage in Diagnostic Hybrids, Cleveland, OH, to perform phenotypic assays to determine drug resistance in clinical samples. Molecular and Cell Biology techniques: Nucleic Acid isolation and Purification, Primer Design and Reaction Optimization, Gel Electrophoresis, Sequencing, Sequence Analysis, RT-PCR, Phylogeny, Drug Resistance Phenotypic Assays. Show less



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Marketing assistant

  • Jan 2006 - Mar 2006

  Internship in the department of Marketing. Preparation of promotional and educational materials. Organization of meetings. Internship in the department of Marketing. Preparation of promotional and educational materials. Organization of meetings.